The Scientific World Journal / 2014 / Article / Tab 1

Clinical Study

Long-Term and Short-Term Effects of Hemodialysis on Liver Function Evaluated Using the Galactose Single-Point Test

Table 1

The demographic data and biochemistry parameters of the patients in the study ( ).

Variables ValuesValue of reference

Demographics
 Age (years)60.38 ± 11.86
 Female (%)28 (37.84)
 Hepatitis B carrier (%)6 (8.18)
 Hepatitis C carrier (%)4 (5.40)
 Predialysis body weight (kg)62.50 ± 9.89
Etiology of end-stage renal disease
 Diabetes mellitus14 (18.9%)
 Polycystic kidney disease2 (2.7%)
 Preclampsia1 (1.4%)
Cormobidity
 Hypertension16 (21.6%)
 Coronary artery disease16 (21.6%)
 Malignancy5 (6.75%)
Medication
 ACEi/ARB9 (12.1%)
 Statin2 (2.7%)
 Phosphate binder39 (52.7%)
 Acetaminophen11 (14.8%)
 Phenytoin2 (2.7%)
 Rifampicin1 (1.4%)
Biochemistry parameters
 Glucose (mg/dL)124.83 ± 68.4590–105
 AST (U/L) 22.19 ± 17.04 40
 ALT (U/L) 18.47 ± 15.38 40
 Alk-p (U/L)78.07 ± 56.2830–95
 Albumin (g/dL)4.05 ± 0.353.5–5.0
 Uric acid (mg/dL)7.24 ± 1.194.0–6.2

VariablesValues

Cr (mg/dL)
 Predialysis11.42 ± 2.02
 Postdialysis4.49 ± 3.32
BUN (mg/dL)
 Predialysis72.71 ± 21.51
 Postdialysis19.13 ± 8.88
Hematocrit (%)
 Predialysis28.60 ± 5.60
 Post-dialysis29.62 ± 6.26
Months of Dialysis (months)60.77 ± 48.23
Pre-dialysis GSP (g/mL)457.94 ± 297.83

Note: = valid cases, AST = Aspartate transaminase, ALT = alanine aminotransferase, Cr = serum creatinine, BUN = blood urea nitrogen, alk-p = alkaline phosphatase, GSP = galactose single point.